rhodioloside has been researched along with Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Q; Liu, C; Liu, Y; Wang, J; Yang, Y; Zhang, X; Zhao, Z; Zhu, Y | 1 |
| Brown, J; Chen, L; Chu, K; Hong, G; Lai, W; Wei, Y; Zhang, X; Zheng, Z | 1 |
2 other study(ies) available for rhodioloside and Stroke
| Article | Year |
|---|---|
Salidroside alleviates ischemic brain injury in mice with ischemic stroke through regulating BDNK mediated PI3K/Akt pathway.
Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Cells, Cultured; Embryo, Mammalian; Forkhead Box Protein O1; Gene Expression Regulation; Glucosides; Male; Mice; Mice, Knockout; Neurons; Phenols; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA Interference; Stroke | 2018 |
Salidroside-Mediated Neuroprotection is Associated with Induction of Early Growth Response Genes (Egrs) Across a Wide Therapeutic Window.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Brain; Brain Ischemia; Caspase 3; Disease Models, Animal; Dose-Response Relationship, Drug; Early Growth Response Transcription Factors; Glucosides; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; PC12 Cells; Phenols; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke; Time Factors | 2015 |